Joint venture in India reshapes the story around Ingredion stock

Ingredion (INGR) just announced a joint venture and a 9% equity stake in India-based Sanstar Limited, including plans for a new greenfield facility focused on specialty pharmaceutical and food ingredients.

Despite the Sanstar joint venture announcement and a recently affirmed quarterly dividend, Ingredion’s share price has slipped, with the 30 day share price return down 9.19% and the year to date share price return down 7.61%. Over a longer window, the 1 year total shareholder return is down 25.06%, although the 5 year total shareholder return of 20.99% shows a very different picture for patient investors.

If this kind of expansion story has you thinking beyond a single stock, it could be a good moment to broaden your search and uncover 20 top founder-led companies

With Ingredion stock down over the past year and trading at a discount to both analyst targets and some intrinsic estimates, the key question is whether this represents a reset that opens a buying window or a sign that markets already see limited future growth priced in.

Most Popular Narrative: 16.8% Undervalued

Ingredion's most followed valuation story pegs fair value at about $121.86 per share, compared with a last close of $101.44, and rests on measured growth and margin assumptions.

Strong consumer and customer demand for health and wellness-focused, clean label, and sugar reduction solutions continues to drive double-digit growth in Ingredion's higher-value specialty portfolio, including clean label starches, high-intensity sweeteners, and protein isolates. This trend is expected to sustain above-average revenue and margin growth for the Texture & Healthful Solutions segment.

Want to see what kind of earnings path and margin profile could justify that valuation gap, and how analysts frame the long run mix shift story?

Result: Fair Value of $121.86 (UNDERVALUED)

However, currency volatility in key LATAM markets and weaker demand for legacy products like industrial starches and high fructose corn syrup could quickly challenge that undervaluation story.

Next Steps

If this mix of risks and rewards leaves you undecided, it can help to move quickly, review the underlying data, and weigh the company's positives for yourself with 6 key rewards.

Looking for more investment ideas?

If Ingredion has you thinking more broadly about where to put fresh capital to work, it makes sense to scan a wider field of high quality candidates.

• Spot opportunities in companies priced below what their fundamentals suggest they could be worth by running your filters through the 46 high quality undervalued stocks.
• Build a watchlist of businesses that prioritize resilience and financial strength by checking the solid balance sheet and fundamentals stocks screener (46 results).
• Get ahead of the crowd by searching the screener containing 22 high quality undiscovered gems before these stories become widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.